Trypanosoma brucei cellular redox system

The **Trypanosoma brucei cellular redox system** refers to a unique network of enzymes and cofactors responsible for maintaining the redox balance in the parasitic protozoan *Trypanosoma brucei*, the causative agent of African trypanosomiasis (sleeping sickness). Unlike most organisms that utilize the glutathione or thioredoxin systems as dominant cellular redox buffers, *T. brucei* primarily relies on the **trypanothione system**, in which the dithiol trypanothione [bis(glutathionyl)spermidine] is kept reduced by the enzyme trypanothione reductase[1][2]. Additional enzymes, including unique thioredoxin-type proteins (such as mitochondrial Trx2[1]) and monothiol glutaredoxins (e.g., 1CGrx1[2]), participate in redox balance, protein folding, oxidative stress protection, and iron–sulfur cluster assembly. Genetic or chemical disruption of these enzymes impairs parasite proliferation and infectivity, validating this system as a therapeutic target for treating sleeping sickness. Several drugs such as suramin and melarsoprol exploit the vulnerability of the redox system, burdening the parasite with overwhelming oxidative stress or disabling DNA synthesis. Despite high therapeutic potential, challenges remain in selective drug design due to the structural diversity and redundancy within the enzymes of this complex system[1][2][5]. Notes: - This entry refers to a **class of functionally related systems** (redox pathways), not a single molecular target. A more specific canonical target—such as "Trypanothione reductase (TR)", "Trypanosoma brucei thioredoxin 2 (Trx2)", or "Trypanosoma brucei monothiol glutaredoxin 1CGrx1"—should be used for structured records[1][2]. - Therefore, **is_incorrect: true**, as the defined scope is too broad for a unique, canonical target.

Other names

Trypanosoma brucei redox metabolismTrypanosoma brucei thiol-dependent redox systemTrypanothione system

Irreversible inhibition of trypanothione reductase (leading to loss of parasite redox homeostasis); Covalent modification of thiol groups necessary for redox enzymes; Direct binding and inhibition of glutaredoxin active sites (experimental)